Related Experiment Video
Updated: Feb 12, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
Risk of recurrent venous thromboembolism according to baseline risk factor profiles
Martin H Prins1, Anthonie W A Lensing2, Paolo Prandoni3
1Department of Epidemiology and Technology Assessment, University of Maastricht, Maastricht, The Netherlands.
Extended anticoagulation may benefit patients with provoked venous thromboembolism (VTE). Recurrence rates were similar for unprovoked VTE and VTE provoked by minor risk factors, suggesting longer treatment is beneficial.
Area of Science:
- Cardiology
- Hematology
- Pharmacology
Background:
- The optimal duration of anticoagulation for venous thromboembolism (VTE) remains uncertain.
- Risk stratification is crucial for guiding extended VTE treatment decisions.
Purpose of the Study:
- To estimate the risk of VTE recurrence based on baseline risk factor profiles.
- To compare extended VTE treatment with rivaroxaban, aspirin, or placebo.
Main Methods:
- Analysis of data from 2 randomized trials involving 2832 patients on rivaroxaban, 1131 on aspirin, and 590 on placebo.
- Central classification of index VTE events as unprovoked or provoked by various risk factors.
- Calculation of 1-year recurrence rates for each treatment group and risk factor profile.
Main Results:
- For unprovoked VTE, 1-year recurrence rates were 2.0% (rivaroxaban), 5.9% (aspirin), and 10.0% (placebo).
- For VTE provoked by minor persistent risk factors, rates were 2.4% (rivaroxaban), 4.5% (aspirin), and 10.7% (placebo).
- For VTE provoked by minor transient risk factors, rates were 0.4% (rivaroxaban), 4.2% (aspirin), and 7.1% (placebo).
Conclusions:
- Recurrence rates for VTE provoked by minor persistent or transient risk factors were not significantly different from unprovoked VTE.
- Patients with VTE provoked by minor risk factors may benefit from extended anticoagulation therapy.
- These findings support individualized extended anticoagulation strategies for VTE management.
Related Concept Videos
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Relative Risk
Design Example: Analyzing Capacity Contours for Flood Risk Assessment
Venous Return
What is Venous Return?
Venous return refers to the rate at which blood flows back to the heart from the body's peripheral veins. It's an integral part of the circulatory system...
Venous Thrombosis I: Introduction
Transcription Factors

